Pharmaceutical Isolator Market Research Report - Global Forecast till 2027

Pharmaceutical Isolator Market: Information by Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Application (Aseptic Isolators, Containment Isolators, Sampling/Weighing/Distribution Isolators, Fluid Dispensing Isolators and others) End User (Hospitals, Pharmaceutical & Biotechnology Companies, Research & Academic Laboratories and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast till 2027

ID: MRFR/Pharma/3262-CR | February 2021 | Region: Global | 117 Pages         

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 18

3.2 Scope of the Study 18

3.3 Research Objective 18

3.4 Assumptions & Limitations 18

3.4.1 Assumptions 18

3.4.2 Limitations 18

3.5 Market Structure 19

4 Research Methodology

4.1 Research Process 21

4.2 Primary Research 22

4.3 Secondary Research 23

4.4 Market Size Estimation 24

4.5 Forecast Model 24

5 Market Dynamics

5.1 Introduction 26

5.2 Drivers 27

5.2.1 Greater Sterility Assurance of Pharmaceutical Isolators 27

5.2.2 Low Operational Cost of Pharmaceutical Isolators 27

5.3 Restraints 27

5.3.1 Availability of Restricted Access Barrier Systems (RABS) for Aseptic Processing 27

5.4 Opportunities 28

5.4.1 Technological Advancements in Pharmaceutical Isolators 28

6 Market Factor Analysis

6.1 Porter’s Five Forces Model 30

6.1.1 Bargaining Power of Suppliers 30

6.1.2 Bargaining Power of Buyers 30

6.1.3 Threat of New Entrants 31

6.1.4 Threat of Substitutes 31

6.1.5 Intense Rivalry 31

6.2 Supply chain analysis 32

6.2.1 R&D and Designing 32

6.2.2 Manufacturing 32

6.2.3 Distribution & Sales 32

6.2.4 Post-Sales Monitoring 32

7 Pharmaceutical Isolator Market, By Type

7.1 Overview 34

7.2 Open Isolator 35

7.3 Closed Isolator 36

8 Pharmaceutical Isolator Market, By Pressure

8.1 Overview 38

8.2 Positive Pressure 39

8.3 Negative Pressure 40

9 Global Pharmaceutical Isolator Market by Application

9.1 Overview 42

9.2 Aseptic Filling 43

9.3 Fluid Dispensing 44

9.4 Sampling/Weighing/Distribution 44

9.5 Product Containment 45

10 Global Pharmaceutical Isolator Market by End-User

10.1 Overview 47

10.2 Pharmaceutical & Biotechnology Companies 48

10.3 Hospitals 49

10.4 Research & Academic Laboratories 49

11 Global Pharmaceutical Isolator Market, by Region

11.1 Introduction 51

11.2 Americas 52

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.2.1 North America 54

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.2.1.1 US 56

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.2.1.2 Canada 57

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.2.2 South America 59

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.3 Europe 61

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.3.1 Western Europe 63

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.3.1.1 Germany 65

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.3.1.2 France 67

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.3.1.3 UK 68

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.3.1.4 Italy 69

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.3.1.5 Spain 71

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.3.1.6 Rest of Western Europe 72

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.3.2 Eastern Europe 73

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.4 Asia Pacific 75

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.4.1 Japan 77

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.4.2 China 78

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.4.3 India 80

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.4.4 Australia 81

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.4.5 South Korea 82

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.4.6 Rest of Asia-Pacific 84

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.5 The Middle East and Africa 85

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.5.1 Middle East 87

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

11.5.2 Africa 88

Pharmaceutical Isolator Market, By Type

Pharmaceutical Isolator Market, By Pressure

12 Competitive Landscape

12.1 Overview 91

13 Company Profiles

13.1 Gelman Singapore Pte Ltd. 93

13.1.1 Company Overview 93

13.1.2 Financial Overview 93

13.1.3 Products Offering 93

13.1.4 SWOT Analysis 93

13.1.5 Key Developments 93

13.1.6 Key strategy 93

13.2 COMECER S.p.A. cf. p.iva 94

13.2.1 Company Overview 94

13.2.2 Financial Overview 94

13.2.3 Products Offering 94

13.2.4 SWOT Analysis 95

13.2.5 Key Developments 95

13.2.6 Key strategy 95

13.3 IsoTech Design 96

13.3.1 Company Overview 96

13.3.2 Company Overview 96

13.3.3 Products Offering 96

13.3.4 SWOT Analysis 97

13.3.5 Key Developments 97

13.3.6 Key strategy 97

13.4 LAF Technologies Pty Ltd. 98

13.4.1 Company Overview 98

13.4.2 Financial Overview 98

13.4.3 Products Offering 98

13.4.4 SWOT Analysis 98

13.4.5 Key Developments 98

13.4.6 Key Strategy 99

13.5 Fedegari Autoclavi S.p.A 100

13.5.1 Company Overview 100

13.5.2 Financial Overview 100

13.5.3 Products Offering 100

13.5.4 SWOT Analysis 100

13.5.5 Key Developments 101

13.5.6 Key Strategy 101

13.6 Hosokawa Micron Ltd 102

13.6.1 Company Overview 102

13.6.2 Financial Overview 102

13.6.3 Products Offering 103

13.6.4 SWOT Analysis 103

13.6.5 Key Development 103

13.6.6 Key Strategy 103

13.7 Robert Bosch GmbH 104

13.7.1 Company Overview 104

13.7.2 Financial Overview 104

13.7.3 Products Offering 105

13.7.4 SWOT Analysis 105

13.7.5 Key Development 105

13.7.6 Key Strategy 105

13.8 MBRAUN 106

13.8.1 Company Overview 106

13.8.2 Financial Overview 106

13.8.3 Products Offering 106

13.8.4 SWOT Analysis 107

13.8.5 Key Development 107

13.8.6 Key Strategy 107

13.9 Schematic Engineering Industries 108

13.9.1 Company Overview 108

13.9.2 Financial Overview 108

13.9.3 Products Offering 108

13.9.4 SWOT Analysis 108

13.9.5 Key Development 109

13.9.6 Key Strategy 109

13.9.7 NuAire Inc. 110

13.9.8 Company Overview 110

13.9.9 Financial Overview 110

13.9.10 Products Offering 110

13.9.11 SWOT Analysis 110

13.9.12 Key Development 110

13.9.13 Key Strategy 110

13.10 VanRx Pharmasystems Inc. 111

13.10.1 Company Overview 111

13.10.2 Financial Overview 111

13.10.3 Products Offering 111

13.10.4 SWOT Analysis 111

13.10.5 Key Developments 112

13.10.6 Key strategy 112

13.11 Azbil Telstar 113

13.11.1 Company Overview 113

13.11.2 Financial Overview 113

13.11.3 Products Offering 114

13.11.4 SWOT Analysis 114

13.11.5 Key Development 114

13.11.6 Key Strategy 114

13.12 Getinge AB 115

13.12.1 Company Overview 115

13.12.2 Financial Overview 115

13.12.3 Products Offering 116

13.12.4 SWOT Analysis 116

13.12.5 Key Development 116

13.12.6 Key Strategy 116

13.13 Skan AG 117

13.13.1 Company Overview 117

13.13.2 Financial Overview 117

13.13.3 Products Offering 117

13.13.4 SWOT Analysis 117

13.13.5 Key Development 117

13.13.6 Key Strategy 118

14 Appendix

14.1 Discussion Blue Print 120

15 List of Tables

TABLE 1 MARKET SYNOPSIS 16

TABLE 2 PRIMARY INTERVIEWS 21

TABLE 3 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020-2027 (USD MILLION) 35

TABLE 4 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR OPEN ISOLATOR BY REGION, 2020 TO 2027 (USD MILLION) 35

TABLE 5 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR CLOSED ISOLATOR BY REGION, 2020 TO 2027 (USD MILLION) 36

TABLE 6 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 39

TABLE 7 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR POSITIVE PRESSURE BY REGION, 2020 TO 2027 (USD MILLION) 39

TABLE 8 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR NEGATIVE PRESSURE BY REGION, 2020 TO 2027 (USD MILLION) 40

TABLE 9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 43

TABLE 10 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR ASEPTIC FILLING BY REGION, 2020 TO 2027 (USD MILLION) 43

TABLE 11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR FLUID DISPENSING BY REGION, 2020 TO 2027 (USD MILLION) 44

TABLE 12 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR SAMPLING/WEIGHING/DISTRIBUTION BY REGION, 2020 TO 2027 (USD MILLION) 44

TABLE 13 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR PRODUCT CONTAINMENT BY REGION, 2020 TO 2027 (USD MILLION) 45

TABLE 14 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 48

TABLE 15 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES BY REGION, 2020 TO 2027 (USD MILLION) 48

TABLE 16 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR HOSPITALS BY REGION, 2020 TO 2027 (USD MILLION) 49

TABLE 17 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR RESEARCH AND ACADEMIC LABORATORIES BY REGION, 2020 TO 2027 (USD MILLION) 49

TABLE 18 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY REGION, 2020 TO 2027 (USD MILLION) 51

TABLE 19 AMERICAS PHARMACEUTICAL ISOLATOR MARKET BY REGION, 2020 TO 2027 (USD MILLION) 52

TABLE 20 AMERICAS PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 53

TABLE 21 AMERICAS PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 53

TABLE 22 AMERICAS PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 53

TABLE 23 AMERICAS PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 54

TABLE 24 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 54

TABLE 25 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 55

TABLE 26 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 55

TABLE 27 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 55

TABLE 28 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 56

TABLE 29 US PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 56

TABLE 30 US PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 56

TABLE 31 US PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 57

TABLE 32 US PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 57

TABLE 33 CANADA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 57

TABLE 34 CANADA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 58

TABLE 35 CANADA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 58

TABLE 36 CANADA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 58

TABLE 37 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 59

TABLE 38 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 59

TABLE 39 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 59

TABLE 40 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 60

TABLE 41 EUROPE PHARMACEUTICAL ISOLATOR MARKET BY REGION, 2020 TO 2027 (USD MILLION) 61

TABLE 42 EUROPE PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 62

TABLE 43 EUROPE PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 62

TABLE 44 EUROPE PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 62

TABLE 45 EUROPE PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 63

TABLE 46 WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 64

TABLE 47 WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 64

TABLE 48 WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 64

TABLE 49 WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 65

TABLE 50 WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 65

TABLE 51 GERMANY PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 65

TABLE 52 GERMANY PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 66

TABLE 53 GERMANY PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 66

TABLE 54 GERMANY PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 66

TABLE 55 FRANCE PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 67

TABLE 56 FRANCE PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 67

TABLE 57 FRANCE PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 67

TABLE 58 FRANCE PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 68

TABLE 59 UK PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 68

TABLE 60 UK PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 68

TABLE 61 UK PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 69

TABLE 62 UK PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 69

TABLE 63 ITALY PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 69

TABLE 64 ITALY PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 70

TABLE 65 ITALY PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 70

TABLE 66 ITALY PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 70

TABLE 67 SPAIN PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 71

TABLE 68 SPAIN PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 71

TABLE 69 SPAIN PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 71

TABLE 70 SPAIN PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 72

TABLE 71 REST OF WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 72

TABLE 72 REST OF WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 72

TABLE 73 REST OF WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 73

TABLE 74 REST OF WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 73

TABLE 75 EASTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 73

TABLE 76 EASTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 74

TABLE 77 EASTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 74

TABLE 78 EASTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 74

TABLE 79 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 75

TABLE 80 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 76

TABLE 81 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 76

TABLE 82 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 76

TABLE 83 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 77

TABLE 84 JAPAN PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 77

TABLE 85 JAPAN PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 77

TABLE 86 JAPAN PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 78

TABLE 87 JAPAN PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 78

TABLE 88 CHINA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 78

TABLE 89 CHINA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 79

TABLE 90 CHINA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 79

TABLE 91 CHINA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 79

TABLE 92 INDIA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 80

TABLE 93 INDIA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 80

TABLE 94 INDIA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 80

TABLE 95 INDIA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 81

TABLE 96 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 81

TABLE 97 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 81

TABLE 98 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 82

TABLE 99 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 82

TABLE 100 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 82

TABLE 101 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 83

TABLE 102 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 83

TABLE 103 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 83

TABLE 104 REST OF ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 84

TABLE 105 REST OF ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 84

TABLE 106 REST OF ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 84

TABLE 107 REST OF ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 85

TABLE 108 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET BY REGION, 2020 TO 2027 (USD MILLION) 85

TABLE 109 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 86

TABLE 110 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 86

TABLE 111 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 86

TABLE 112 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 87

TABLE 113 MIDDLE EAST PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 87

TABLE 114 MIDDLE EAST PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 87

TABLE 115 MIDDLE EAST PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 88

TABLE 116 MIDDLE EAST PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 88

TABLE 117 AFRICA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 88

TABLE 118 AFRICA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 89

TABLE 119 AFRICA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 89

TABLE 120 AFRICA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 89

16 List of Figures

FIGURE 1 RESEARCH PROCESS 21

FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH 24

FIGURE 3 MARKET DYNAMICS ANALYSIS OF GLOBAL PHARMACEUTICAL ISOLATOR MARKET 26

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PHARMACEUTICAL ISOLATOR MARKET 30

FIGURE 5 SUPPLY CHAIN: GLOBAL PHARMACEUTICAL ISOLATOR MARKET 32

FIGURE 6 GLOBAL PHARMACEUTICAL ISOLATOR MARKET SHARE, BY TYPE, 2020 (%) 34

FIGURE 7 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 & 2027 (USD MILLION) 34

FIGURE 8 GLOBAL PHARMACEUTICAL ISOLATOR MARKET SHARE, BY PRESSURE, 2020 (%) 38

FIGURE 9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 & 2027 (USD MILLION) 38

FIGURE 10 GLOBAL PHARMACEUTICAL ISOLATOR MARKET SHARE, BY APPLICATION, 2020 (%) 42

FIGURE 11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 & 2027 (USD MILLION) 42

FIGURE 12 GLOBAL PHARMACEUTICAL ISOLATOR MARKET SHARE, BY END-USER, 2020 (%) 47

FIGURE 13 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 & 2027 (USD MILLION) 47

FIGURE 14 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY REGION, 2020 & 2027 (USD MILLION) 51

FIGURE 15 AMERICAS PHARMACEUTICAL ISOLATOR MARKET SHARE BY REGION, 2020 (%) 52

FIGURE 16 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET SHARE BY COUNTRY, 2020 (%) 54

FIGURE 17 EUROPE PHARMACEUTICAL ISOLATOR MARKET SHARE BY REGION, 2020 (%) 61

FIGURE 18 WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET SHARE BY COUNTRY, 2020 (%) 63

FIGURE 19 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET SHARE BY COUNTRY, 2020 (%) 75

FIGURE 20 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET SHARE BY REGION, 2020 (%) 85

Pharmaceutical Isolator Market

Pharmaceutical Isolator Market will grow at CAGR of 7.15% to hit $ 180.15 Million by 2030

Segmentation

By Type Open Isolator Closed Isolator
By Pressure Positive Pressure Negative Pressure
By Application Aseptic Isolators Containment Isolators Sampling/Weighing/Distribution Isolators Fluid Dispensing Isolators
By End User Hospitals Pharmaceutical & Biotechnology Companies Research & Academic Laboratories

Key Players

  • AzbilTelstarSkanAGGetinge AB
  • VanRxPharmasystems Inc.
  • Schematic Engineering Industries
  • NuAire Inc.
  • Robert Bosch GmbH
  • MBRAUN
  • FedegariAutoclaviSpA
  • Hosokawa Micron Ltd
  • IsoTech Design
  • COMECER SpA cf. p.iva

Drivers

  • The immense sterility assurance of pharmaceutical isolators results
  • low operational costs
Speak to Analyst Request a Free Sample

Pharmaceutical Isolator Market Overview


The pharmaceutical isolator market is the fastest evolving market of recent times, and it will further propel to greater heights in the near future. The market value is estimated to reach around USD 32,944.3 million by 2023. The compound annual growth rate (CAGR) is predicted to be 7.86 percent in the forecast period from 2017 to 2023.


Pharmaceutical isolators are designed specifically for the purpose of keeping away any sort of contamination during the process of manufacturing and other procedures of product handling. The pharmaceutical isolator market enables to safeguard of the operator from exposure of drugs, removing the possibilities of cross-contamination as well as maintaining the drug quality standard. In the pharmaceutical isolator industry, maintaining immense caution during the product manufacturing process is extremely important. Different types of isolator in pharmaceutical market provide an optimum level of sterility in the product manufacturing process. The production of pharmaceuticals with high potency ingredients like hormones, cytostatic, antibiotics needs a greater level of precautions which will enhance the expansion of market size.


The pharmaceutical isolator vendors do not even sell the isolators at a higher price, and in fact, these isolators are way more feasible than the traditional clean-rooms. In the disinfected clean rooms, there is a chance that the operator can bring contamination to a limited amount. However, the isolators in the pharmaceutical isolator industry provide a bio-decontaminated environment that only allows drugs and material in direct contact with the manufacturing processing system. All these features fuel the pharmaceutical isolator market growth and help in attaining maximum heights in the forecast period. The rising demand of pharmaceutical industries and manufacturing of drugs, expenditure increase in research and development work, and stringent government policies and regulations for maintaining drug safety and efficacy leads to the increase in the potential of the market.


The report highlights the in-depth analysis of the global market and the impact of the COVID19 pandemic on the market. It covers the market dynamics and key players that will drive the market in the forecast period. The report explains the market segmentation and puts light on different regions that can influence the pharmaceutical isolator market growth in the near future.


COVID19 Analysis


The coronavirus outbreak resulted in a big crisis both in the field of health as well as the economy. The global economic growth rate decelerated to the lowest limits. Many manufacturing industrial operations were put at a halt due to the stringent lockdown measures. However, the health care sector was still in demand as the coronavirus created a health crisis all around the world. The concern of health issues increased the demand for medicines which escalated the growth of pharmaceutical industries. As the pharmaceutical industries and drug manufacturing processes are growing day by day, the demand for the pharmaceuticalisolator market is also elevating. The pharmaceutical isolator industry maintained a steady growth rate and contributed much more to the global economy.


The global health crisis required a large amount of drug production for recovering from illness and a surge of new medicines manufactured worldwide to fulfill the purpose. Manufacturing medicines require intense care and proper handling, which the market can provide, and the rise in manufacturing processes with evolving the market growth. In the upcoming years, the demand for the pharmaceutical isolator market will further escalate and will reach optimum limits.


Market Dynamics



  • Major drivers of the market


The pharmaceutical isolator market growth is skyrocketing in the global economy, and the pharmaceutical sector is the primary driving force of the market. The immense sterility assurance of pharmaceutical isolators results in expanding the market size. The preparations of the manufacturing process include the involvement of active pharmaceutical ingredients or APIs that have high potency and contain substances like hormones, antibiotics, and cytostatic. These processes require extreme caution and safety measures to avoid any sort of contamination, and the market exactly provides the necessary amount of product safety. The pharmaceutical isolator technology market allows access to a secure environment that ensures the operator’s safety and maintains the quality standard of the finished product.


Another efficient driver of pharmaceutical isolator market growth is its low operational costs. The pharmaceutical isolator vendors give the isolators to the pharmaceutical industries at a much cheaper rate compared to the traditional clean-rooms. The sanitized and disinfected clean-rooms have chances of contamination due to operator intervention. However, the pharmaceutical isolator industry limits contamination and provides a bio-decontaminated condition where only the drug and manufacturing material comes in contact with the entire processing system.


The bio-decontaminated environment inside the isolator is the result of cleaning the working area with hydrogen peroxide. The automated bio-decontamination process enables repeated high levels of disinfectant in the interior of the pharmaceutical isolator. The sterility assurance level (SAL) is way higher than the sanitized clean rooms, which will effectively propel the pharmaceutical isolator market growth.



  • Significant Opportunities for the market


Various technological advancements in the pharmaceutical isolator market will upsurge the market growth opportunities in the forecast years. The modern technological trends will lead to an increase in the future of robotics technology in the pharmaceutical isolator industry. In the manufacturing process of pharmaceutical industries, repeating the production procedure is mandatory as it raises the quality reproducibility, which can only be obtained with the advent of robotics technology.


The introduction of robotics technology to the pharmaceutical isolator market will enhance the level of quality as well as accuracy. So, the research and technology sector is constantly working on robotics technology to emerge better product ideas in the future. With the surfacing of robotics technology in pharmaceutical industries, the pharmaceutical technology isolator market will also attain greater heights.



  • Market Restraint


The pharmaceutical isolator market was impacted by the outbreak of the COVID19 pandemic and behaved as a major restrain in the path of market growth. The manufacturing processes in industries were closed for an uncertain time period. The global economy took a downturn during the pandemic. However, the market growth sustained even in the hasher situation. The coronavirus outbreak surges a health crisis worldwide, and the demand for pharmaceutical productions elevated to a greater extent. The rising need for pharmaceuticals resulted in increasing demand for the pharmaceutical technology isolator market, which will lead to market growth in the forecast period.



  • Market growth challenges


There is no doubt that the pharmaceutical isolator industry is going to emerge rapidly in the upcoming years. However, some challenges can hamper the expansion path of market size. The implementation and maintenance cost of pharmaceutical isolators are costly, which can result in hindering the growth of the pharmaceutical isolator market. The incorporation of restricted access barrier systems (RABS) in the healthcare industry is another challenge in the growth of the pharmaceutical isolator technology market. The advanced technology can occupy a major share in the market which can hinder the growth of the market in the next many years.


Value Chain Analysis


The revenue generated by the market in recent times has surpassed the market value of historical years. By the end of 2023, the market will attain optimum levels of value and increase the market size. The demand for pharmaceuticals production is booming, which in turn will increase the pharmaceutical isolator industry in the upcoming years.


Segment Overview


The pharmaceutical isolator market is segmented on the basis of type, pressure, application, end-user, and region. The market segmentation on the basis of type includes open systems and closed systems. The open system isolator market size is the largest in the pharmaceutical technology isolator market as these are easy to operate, validate, and quite inexpensive isolators. The increase in manufacturing of products and contract manufacturing services in the pharmaceutical sector can fuel the open system isolator market growth. The pressure segment comprises positive and negative pressure.


Pharmaceutical isolator market segmentation on the basis of application includes aseptic filling, sampling or weighing or distribution, fluid dispensing, product containment, and others. The market segmentation on the basis of end-user involves hospitals, pharmaceutical and biotechnology companies, research and academic laboratories, and many more. The region segment includes analysis of different geographies like North America, South America, Asia Pacific, Europe, Middle East, and Africa.


Regional Analysis


The pharmaceutical isolator market is studied in different regions such as North America, South America, Asia Pacific, Europe, Middle East, and Africa. The North American region dominates the market in current times and will continue to influence in the forecast years. Biotechnology laboratories will boost the market growth, and it is expected to reach USD 12,142.2 million by 2023. Europe is presumed to hold a CAGR of 7.31 percent, whereas the Asia Pacific market can hold a CAGR of 8.73 percent in the forecast period.


Competitive Landscape of the market


The prominent players of the pharmaceutical isolator market are:



  • AzbilTelstarSkanAGGetinge AB

  • VanRxPharmasystems Inc.

  • Schematic Engineering Industries

  • NuAire Inc.

  • Robert Bosch GmbH

  • MBRAUN

  • FedegariAutoclaviSpA

  • Hosokawa Micron Ltd

  • IsoTech Design

  • COMECER SpA cf. p.iva

  • LAF Technologies Pty Ltd

  • Gelman Singapore Pte Ltd



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 32,944.3 million
  CAGR   7.30% (2021-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Pressure, Application, End User and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   AzbilTelstarSkanAGGetinge AB, VanRxPharmasystems Inc., Schematic Engineering Industries, NuAire Inc., Robert Bosch GmbH, MBRAUN, FedegariAutoclaviSpA, Hosokawa Micron Ltd, IsoTech Design, COMECER SpA cf. p.iva, LAF Technologies Pty Ltd, Gelman Singapore Pte Ltd
  Key Market Opportunities   Various technological advancements in the pharmaceutical isolator market
  Key Market Drivers

  • The immense sterility assurance of pharmaceutical isolators results
  • low operational costs


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The predicted valuation is USD 32,994.3 million by 2027.

    The market valuation was USD 20,876.4 million in 2017.

    The market would be led by an open isolator market.

    The positive pressure segment would dominate the market.

    Company Landscape

    There are numerous small and large players operating in the global pharmaceutical isolator market. Some of them include Skan AG, Hosokawa Micron Ltd, Azbil Telstar, Getinge AB, Robert Bosch GmbH, and COMECER S.p.A. cf. p.iva, among others.


    Skan AG is one of the prominent players in the market. The company is engaged in developing cleanroom and isolator equipment for the pharmaceutical industry. The company has a global presence with a strong distribution network. Skan AG mainly focuses on strategic partnerships to strengthen its presence globally. For instance, in September 2017, the company signed a partnership with the ITS Group. This partnership aimed at strengthening Skan AG’s presence in the field of isolator technology in Singapore and Indonesia.


    Getinge AB is a prominent player operating in the market. The company specializes in medical technology and provides products and solutions to healthcare and life science companies. The company has a worldwide presence with operations in more than 40 countries and sales in about 150 countries. Getinge AB focuses on the development of innovative product portfolio and on strengthening its position in niche segments.


    Hosokawa Micron Ltd is also one of the major players in the global market. The company has a diverse range of products. The company focuses on increasing its footprints in the nanoparticle technology segment. Apart from this, the company focuses on manufacturing innovative products.


    COMECER S.p.A. cf. p.iva is engaged in the manufacturing of high technology systems in the field of aseptic processing and contaminant for pharmaceutical and nuclear medicine industries. The company has a wide range of products based on the isolation technology. The company mainly focuses on strategic collaborations and mergers. For instance, in May 2018, the company along with its US-based subsidiary, Comecer America, announced a collaboration with Advaxis company to produce an aseptic manufacturing system (isolation technology).


    Apart from these companies, there is a large number of companies operating in the pharmaceutical isolator market. These companies are based in different regions such as the Americas, Asia-Pacific, Europe, and the Middle East and Africa. These companies are involved in the development of equipment based on the isolation technology for use in the pharmaceutical and biotechnological industry.